CATX

Perspective Therapeutics Inc.

Price

$3.48

return (12m)

1.75%

p/e

-3.33

p/bv

1.20

DIVIDEND YIELD

0.00%

CATX price

Perspective Therapeutics Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CATX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.97%

3 months

-10.08%

1 year

1.75%

2 years

-76.50%

5 years

-44.76%

10 years

-54.81%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CATX

Valuation

P/E

-3.33

Sector 7.79

Industry 7.79

P/BV

1.20

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.22

Industry 2.22

EV/EBITDA

-5.91

Sector -156.98

Industry -156.98

EV/EBIT

-5.66

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-3.43

Sector 2.51

Industry 2.51

P/EBIT

-3.31

Sector 0.34

Industry 0.34

P/Total Assets

0.99

Sector 1.00

Industry 1.00

P/Net Current Assets

2.24

Sector -3.84

Industry -3.84

P/Working Capital

1.89

Sector -5,077.26

Industry -5,077.26

EPS

-0.96

Sector 0.67

Industry 0.67

BVPS

2.68

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

0.00%

Sector 32.61%

Industry 32.61%

EBITDA Margin

Sector -284.80%

Industry -284.80%

EBIT Margin

Sector -4.02%

Industry -4.02%

Operating Margin

0.00%

Sector 4.45%

Industry 4.45%

Net Profit Margins

0.00%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-35.95%

Sector 2.05%

Industry 2.05%

ROA

-29.70%

Sector -0.90%

Industry -0.90%

ROIC

-78.53%

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

6.61

Sector 1.44

Industry 1.44

Net Debt / EBITDA

9.13

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

8.75

Sector -31.03

Industry -31.03

Net Debt / Equity

-0.73

Sector -0.72

Industry -0.72

Gross Debt / Equity

0.00

Sector 0.21

Industry 0.21

Equity/Assets

0.83

Sector 0.43

Industry 0.43

Liabilities/Assets

0.17

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

83.22%

Sector -

Industry -

Fundamentals CATX

DRAG THE FRAME TO SEE MORE DATA

CATX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Perspective Therapeutics Inc.

Perspective Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Perspective Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $387.59 million, with shareholders equity totaling $323.86 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Perspective Therapeutics Inc. reported $- in revenue, generating net income of $-116.44 million.

Key financial metrics include a P/E ratio of -3.33, a price-to-book (P/B) ratio of 1.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CATX.

Market cap

$387.59 million

Net worth

$323.86 million

$323,860,000.00

Assets

$392.02 million

$392,020,000.00

Total Shares Outstanding

121.00 million

121,000,000

Average Daily Trading Volume

$1.82 million

$1,815,842.62

Sector

Others

Industry

Others

CATX

CATX revenue and profits

Financial Results CATX

DRAG THE FRAME TO SEE MORE DATA

CATX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96